Cyclerion Therapeutics, Inc.
CYCN
Revenue
0.00
0.000.00%
3 Months ChangeAssets
10.07M
▼-1.30M▼-11.43%
3 Months ChangeLiabilities
1.28M
▼-159.00k▼-11.03%
3 Months ChangeFree Cash Flow
-30.59M
▲5.50M▲15.24%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-07
Form 8-K
ID: 0001193125-24-195410
2024-08-07
Form 10-Q
ID: 0000950170-24-092257
2024-06-14
Form 8-K
ID: 0001193125-24-161591
2024-05-07
Form 10-Q
ID: 0000950170-24-054602
2024-04-18
Form 8-K
ID: 0001193125-24-100763
2023-12-04
Form 8-K
ID: 0001193125-23-288498
2023-12-01
Form 8-K
ID: 0001193125-23-286790
2023-11-24
Form 8-K
ID: 0001193125-23-282705
2023-11-13
Form 10-Q
ID: 0000950170-23-063023
2023-10-23
Form 8-K
ID: 0001140361-23-049190